| 2025-08-08 |
详情>>
股本变动：
变动后总股本38423.41万股
|
| 2025-08-06 |
详情>>
内部人交易：
ERICKSON RONALD P股份增加335000.00股
|
| 2025-08-05 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-2.92美元,归母净利润-1198.75万美元,同比去年增长9.25%
|
| 2025-06-30 |
股东大会：
将于2025-07-24召开股东大会
会议内容 ▼▲
- 1.To approve an amendment to our Articles of Incorporation to increase the number of authorized shares of common stock from 7,500,000 to 750,000,000 (the “Authorized Common Stock Increase Proposal”);
2.To approve (i) the issuance of shares of common stock representing more than 19.99% of common stock outstanding as of June 6, 2025 and (ii) the change of control resulting therefrom, upon the closing of a private placement pursuant to that certain Securities Purchase Agreement, dated June 6, 2025, by and between the Company and Goldeneye 1995 LLC, in accordance with NYSE American Rules 713(a)(ii) and 713(b) (the “Private Placement Proposal”);
3.To approve an amendment to the Know Labs, Inc. 2021 Equity Incentive Plan (the “2021 Plan”) to increase the number of shares of Common Stock authorized for issuance under the 2021 Plan by 48,950,000 shares (the “Amendment of Incentive Plan Proposal”);
4.To approve the adjournment of the meeting in the event that the number of shares of common stock present or represented by proxy at the meeting and voting “FOR” the adoption of the foregoing proposals are insufficient to approve such proposals (the “Adjournment Proposal”).
|
| 2025-06-13 |
复牌提示：
2025-06-13 09:46:13 停牌，复牌日期 2025-06-13 09:51:13
|
| 2025-05-14 |
详情>>
业绩披露：
2025年中报每股收益-2.95美元,归母净利润-830.08万美元,同比去年增长7.84%
|
| 2025-02-14 |
详情>>
业绩披露：
2025年一季报每股收益-0.04美元,归母净利润-469.81万美元,同比去年增长-33.84%
|
| 2025-01-17 |
股东大会：
将于2025-03-07召开股东大会
会议内容 ▼▲
- 1.To approve an amendment to our Articles of Incorporation to effect a reverse stock split of our common stock, by a ratio of not more than 1-for-15, with the exact ratio and the implementation and timing of such reverse stock split to be determined in the discretion of the Board without further approval or authorization of our stockholders (“Reverse Split Proposal”)
2.To consider and vote upon adjournment of the Special Meeting in order to solicit additional proxies if there are not sufficient shares to be voted in favor of any of the foregoing proposals at the time of the Special Meeting.
|
| 2024-11-14 |
详情>>
业绩披露：
2024年年报每股收益-0.2美元,归母净利润-1689.51万美元,同比去年增长17.36%
|
| 2024-10-07 |
股东大会：
将于2024-10-25召开股东大会
会议内容 ▼▲
- 1.To approve an amendment to our Articles of Incorporation to increase the number of authorized shares of Common Stock from 200 million to 300 million;
2.To approve an amendment to the Know Labs, Inc. 2021 Equity Incentive Plan (the “2021 Plan”) to increase the number of shares of Common Stock authorized for issuance under the 2021 Plan to 40,000,000;
3.To consider and vote upon adjournment of the Special Meeting in order to solicit additional proxies if there are not sufficient shares to be voted in favor of any of the foregoing proposals at the time of the Special Meeting.
|
| 2024-08-14 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.16美元,归母净利润-1321万美元,同比去年增长23.72%
|
| 2024-08-14 |
财报披露：
美东时间 2024-08-14 盘后发布财报
|
| 2024-08-12 |
股东大会：
将于2024-09-26召开股东大会
会议内容 ▼▲
- 1.To elect seven nominees to serve on the Board of Directors of the Company (the “Board”) until the 2025 Annual Meeting of Stockholders;
2.To ratify the appointment of BPM, LLP of Walnut Creek, CA as the Company’s independent registered public accounting firm for the fiscal year ending September 30, 2024;
3.To authorize, for purposes of complying with NYSE American Rule 713, the issuance of shares of our common stock underlying convertible notes and warrants issued pursuant to the terms and provisions of that certain Securities Purchase Agreement, dated February 27, 2024, by and among the Company and Lind Global Fund II LP (“Lind”) in an amount equal to or in excess of 20% of our common stock outstanding;
4.To approve, by a non-binding advisory vote, the compensation of the Company’s named executive officers as disclosed in the attached Proxy Statement;
5.To transact such other business that may properly come before the Annual Meeting and at any adjournments thereof.
|
| 2024-05-15 |
详情>>
业绩披露：
2024年中报每股收益-0.11美元,归母净利润-900.65万美元,同比去年增长-2.9%
|
| 2024-02-14 |
详情>>
业绩披露：
2024年一季报每股收益-0.04美元,归母净利润-351.03万美元,同比去年增长8.18%
|
| 2023-12-19 |
详情>>
业绩披露：
2023年年报每股收益-0.41美元,归母净利润-2044.31万美元,同比去年增长-1.85%
|
| 2023-08-14 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.36美元,归母净利润-1731.77万美元,同比去年增长-19.43%
|
| 2023-08-04 |
股东大会：
将于2023-09-22召开股东大会
会议内容 ▼▲
- 1.To elect four nominees to serve on the Board of Directors of the Company (the “Board”) until the 2024 Annual Meeting of Stockholders;
2.To ratify the appointment of BPM, LLP of Walnut Creek, CA as the Company’s independent registered public accounting firm for the fiscal year ending September 30, 2023;
3.To approve, by a non-binding advisory vote, the compensation of the Company’s named executive officers as disclosed in the attached proxy statement;
4.To approve, by a non-binding advisory vote, the frequency of future advisory votes on the compensation of the Company’s named executive officers;
5.To transact such other business that may properly come before the Annual Meeting and at any adjournments thereof.
|
| 2023-05-15 |
详情>>
业绩披露：
2023年中报每股收益-0.18美元,归母净利润-875.31万美元,同比去年增长23.87%
|